Dentsply Sirona Stock Alpha and Beta Analysis
| XRAY Stock | USD 11.27 0.16 1.40% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Dentsply Sirona. It also helps investors analyze the systematic and unsystematic risks associated with investing in Dentsply Sirona over a specified time horizon. Remember, high Dentsply Sirona's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Dentsply Sirona's market risk premium analysis include:
Beta 1.72 | Alpha (0.23) | Risk 2.52 | Sharpe Ratio (0.05) | Expected Return (0.11) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Dentsply Sirona Backtesting, Dentsply Sirona Valuation, Dentsply Sirona Correlation, Dentsply Sirona Hype Analysis, Dentsply Sirona Volatility, Dentsply Sirona History and analyze Dentsply Sirona Performance. Dentsply Sirona Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Dentsply Sirona market risk premium is the additional return an investor will receive from holding Dentsply Sirona long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Dentsply Sirona. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Dentsply Sirona's performance over market.| α | -0.23 | β | 1.72 |
Dentsply Sirona expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Dentsply Sirona's Buy-and-hold return. Our buy-and-hold chart shows how Dentsply Sirona performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Dentsply Sirona Market Price Analysis
Market price analysis indicators help investors to evaluate how Dentsply Sirona stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dentsply Sirona shares will generate the highest return on investment. By understating and applying Dentsply Sirona stock market price indicators, traders can identify Dentsply Sirona position entry and exit signals to maximize returns.
Dentsply Sirona Return and Market Media
The median price of Dentsply Sirona for the period between Sun, Oct 5, 2025 and Sat, Jan 3, 2026 is 11.4 with a coefficient of variation of 7.46. The daily time series for the period is distributed with a sample standard deviation of 0.86, arithmetic mean of 11.59, and mean deviation of 0.76. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
| Dentsply Sirona dividend paid on 10th of October 2025 | 10/10/2025 |
1 | DENTSPLY SIRONAs Outperform Rating Reaffirmed at Barrington Research | 10/30/2025 |
2 | Dentsply Sirona Non-GAAP EPS of 0.37 misses by 0.08, revenue of 904M beats by 6.27M | 11/06/2025 |
3 | 3 Healthcare Stocks Topping a 2025 List of Dividend Yields | 11/13/2025 |
4 | Magnetar Financial LLC Buys 13,619 Shares of DENTSPLY SIRONA Inc. XRAY | 11/25/2025 |
5 | Disposition of 8737 shares by Robert Johnson of Dentsply Sirona at 11.34 subject to Rule 16b-3 | 11/28/2025 |
6 | DENTSPLY SIRONA Named Top Dividend Stock With Insider Buying and 5.64 percent Yield - Nasdaq | 12/01/2025 |
7 | Dentsply Sirona Reassessing Valuation After Michael Pomeroys Appointment as Interim CFO | 12/05/2025 |
8 | How Investors Are Reacting To DENTSPLY SIRONA Appointing an Interim CFO With Turnaround Expertise | 12/08/2025 |
9 | Acquisition by Kevin Czerney of 96500 shares of Dentsply Sirona at 11.11 subject to Rule 16b-3 | 12/09/2025 |
10 | RBF Capital LLC Takes 3.18 Million Position in DENTSPLY SIRONA Inc. XRAY - MarketBeat | 12/10/2025 |
11 | Dentsply Sirona declares 0.16 dividend | 12/15/2025 |
12 | DENTSPLY SIRONA Strategic RD Investments and Market Recovery Potential Drive Buy Rating - TipRanks | 12/18/2025 |
13 | Acquisition by Mazelsky Jonathan Jay of 2637 shares of Dentsply Sirona subject to Rule 16b-3 | 01/02/2026 |
About Dentsply Sirona Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Dentsply or other stocks. Alpha measures the amount that position in Dentsply Sirona has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0154 | 0.0327 | 0.0294 | 0.0309 | Price To Sales Ratio | 1.9 | 1.02 | 0.92 | 1.8 |
Dentsply Sirona Upcoming Company Events
As portrayed in its financial statements, the presentation of Dentsply Sirona's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dentsply Sirona's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Dentsply Sirona's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Dentsply Sirona. Please utilize our Beneish M Score to check the likelihood of Dentsply Sirona's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Dentsply Sirona
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Dentsply Stock Analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.